According to healthcare research firm 3 Axis Advisors, drugmakers are planning to raise U.S. prices on medications including ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...

The post The FDA Often Doesn’t Test Generic Drugs for Quality Concerns, So ProPublica Did appeared first on ProPublica.

Supply from drugmakers for the stimulant medications most commonly prescribed for ADHD are still falling short of demand, the Food and Drug Administration says, and many Americans who rely on these ...

Forbes contributors publish independent expert analyses and insights. The U.S. spent $722.5 billion on pharmaceuticals in 2023. Although brand-name drugs consume four out of every 5 dollars America ...

INDIANAPOLIS — When you are out shopping, you often see labels showing where the product is made. But look at your generic medication and there is a good chance the "made in" line is missing. Dr.

In response to the ongoing shortage of ADHD medications, the U.S. Food and Drug Administration (FDA) has approved several generic versions of Vyvanse ...

Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug pricing deals.

U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S.

Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, ...

Have you ever tried to fill a prescription only to be turned away by your pharmacy because it’s out of stock? Drug shortages happen when there’s not enough supply of a drug to meet current or expected ...

Generic drugs account for more than 90 percent of prescriptions filled in the United States. Recent studies have found concering variability in quality and safety America’s generic drug supply, most ...